Tyrosine Kinase Inhibitor Library

Kat.-Nr.L1800

Eine einzigartige Sammlung von 653 Tyrosinkinase-Inhibitoren für High-Throughput-Screening (HTS) und High-Content-Screening (HCS).

96 well plates

Passen Sie Ihre Bibliothek an:

Zitiert von 329 Publikationen

Beschreibung & Vorteile

• A unique collection of 653 tyrosine kinase inhibitors for high throughput screening (HTS) and high content screening (HCS)
 
• Targets tyrosine kinases such as EGFR, VEGFR, SRC, c-Met and JAK,etc
 
• Some tyrosine kinase inhibitors have been approved by FDA
 
• Structurally diverse, medicinally active and cell permeable
 
• Rich documentation with structure and customer reviews
 
• NMR and HPLC to ensure the high purity

Produktdetails

Formulierung 620 compounds pre-dissolved in 10mM DMSO, 6 compounds pre-dissolved in 10mM water and 27 compounds pre-dissolved in 2mM DMSO
Behälter 96 Deep-Well-Platte mit Aluminiumfolie versiegelt
Stabilität 12 months -20°C in DMSO
24 months -80°C in DMSO
Versand Kühlakku oder Trockeneis

Fallstudien mit Selleck Compound-Bibliotheken

Tyrosine Kinase Inhibitor Library Zusammensetzung

HTS-Anlagenpartner

  • Collaborating with Seleck: Yale University | Yale Center for Molecular Discovery
  • Collaborating with Seleck: Carbone Cancer Center | University of Wisconsin-Madison
  • Collaborating with Seleck: University of Colorado Denver | CU Denver
  • Collaborating with Seleck: Leibniz-Forschungsinstitut für Molekulare Pharmakologie: Leibniz-FMP
  • Collaborating with Seleck: UCSF_University of California San Francisco
  • Collaborating with Seleck: KU | High Throughput Screening Laboratory
  • Collaborating with Seleck: CIBIO
  • Collaborating with Seleck: Perelman school of medicine | University of Pennsylvania